InvestorsHub Logo
Followers 3
Posts 485
Boards Moderated 0
Alias Born 03/13/2013

Re: None

Thursday, 06/12/2014 9:02:09 AM

Thursday, June 12, 2014 9:02:09 AM

Post# of 5007

RXi Pharma Advances sd-rxRNA Platform with Key Paten

June 9, 2014 9:57 AM

RXi Pharmaceuticals Corp. (RXII) has developed a unique platform, known as sd-rxRNA, that bridges the gap between antisense and RNAi. The technology has a single-stranded phosphorothioate region, a short duplex region, and contains a variety of nuclease-stabilizing and lipophilic chemical modifiers. These features provide both efficiency cellular uptake and long-lasting intracellular activity.










Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News